Pharmabiz

Kindeva appoints Daniel Couto as executive vice president, inhalation & specialty

Kindeva appoints Daniel Couto as executive vice president, inhalation & specialty: Woodbury, Minnesota Wednesday, November 4, ...
Pharmabiz

AstraZeneca appoints Naveen Krishna Yamarthi as managing director of India operations

AstraZeneca appoints Naveen Krishna Yamarthi as managing director of India operations: Our Bureau, Bengaluru Wednesday, ...
Pharmabiz

Biocon Q2FY27 revenues at Rs. 4,389 crore up by 2%, net profit dips by 51% at Rs. 41 crore

Biocon Q2FY27 revenues at Rs. 4,389 crore up by 2%, net profit dips by 51% at Rs. 41 crore: Our Bureau, Bengaluru Wednesday, November 4, 2026, 17:25 Hrs [IST] Biocon in its consol ...
Pharmabiz

Alembic Pharma Q2 net profit rises 81%

Our Bureau, Mumbai Wednesday, November 4, 2026, 17:15 Hrs [IST] Alembic Pharmaceuticals Limited reported its consolidated financial results ...
Pharmabiz

CellProthera selected for JETRO’s Japan Entry Acceleration Programme

CellProthera selected for JETRO’s Japan Entry Acceleration Programme: Mulhouse, France Wednesday, November 4, 2026, 17:00 Hrs [IST] CellProthera, a clinical-stage company develo ...
Pharmabiz

Lupin launches raltegravir tablets in US

Our Bureau, Mumbai Wednesday, November 4, 2026, 16:30 Hrs [IST] Global pharma major Lupin Limited announced the launch of raltegravir tab ...
Pharmabiz

Nephrocare Health Services Q2 revenue up 23.5%

Nephrocare Health Services Limited announced its financial results for the second quarter and half year ended 30th September, 2026. The company's Q2 revenue up 23.5% to Rs.303.4 crore. The company ...
Pharmabiz

Moberg Pharma receives US patent relating to an improved dosing regimen for MOB-015

Moberg Pharma AB, a Swedish pharmaceutical company, announced that the United States Patent and Trademark Office (USPTO) has granted a patent relating to an improved dosing regimen for MOB-015, the ...
Pharmabiz

Metropolis Healthcare Q2 PAT up 43%

Ameera Shah-led Metropolis Healthcare Limited, one of India’s leading diagnostic chains, announced its unaudited consolidated financial results for the quarter ended 30th September 2026. The company's ...
Pharmabiz

Zydus Lifesciences Q2 revenue up 29%

Zydus Lifesciences Ltd. announced its unaudited consolidated financial results for the quarter and half year ended September 30, 2026. The company's revenue from operations at Rs. 79,096 million, up ...
Pharmabiz

OGT expands range of CytoCell IVDR-certified FISH probes for haematological malignancies

OGT expands range of CytoCell IVDR-certified FISH probes for haematological malignancies: Oxford, UK Wednesday, November 4, 2026, 15:00 Hrs [IST] OGT, a leading global provider of ...
Pharmabiz

Medical cost growth in India expected to slow to 10.1% in 2027: Aon Report

Medical cost growth in India expected to slow to 10.1% in 2027: Aon Report: Our Bureau Bengaluru Wednesday, November 4, 2026, 14:45 Hrs [IST] Aon plc (a leading global professiona ...